What could strengthen or challenge TransDigm Group’s outlook?
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Higher potential upsideImproving expectations
Next-FY EPS estimate change · 30 days
Comparable estimates unavailable
+10% or more+5%0%−5%−10% or less
A matching fiscal period and sufficient coverage are required.
Higher risk of downsideWeakening expectations
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
How this is measured
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living FV™
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Management stated this priority in 3 of last 3 quarters. Share repurchases totaled approximately $1.8 billion year-to-date through 2026-Q2, including $1.0 billion in 2026-Q2 alone. The company is delivering on its capital return commitment through consistent repurchase activity.
Delivery assessment Oct 15, 2026
EPS near $34.6 in Q3 2026
Earnings per share are expected near $34.6 in Q3 2026.
Intact
EPS falls below $33.9 in Q3 2026
Diluted EPS: $9.39 per share
FY2026-Q3; GAAP. Published target: ~$34.6 per share. Target period is not explicitly aligned with this observation.
Source published Aug 4, 20269.39 USD/share · source valueSource reportLast status assessment Oct 15, 2026Measurement source
Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management context
Stated as a priority in 3 of last 3 quarters. Revenue grew from $8,831 million in fiscal 2025 to guidance of $10,470-$10,550 million for fiscal 2026, a 19% increase at midpoint. Management has consistently raised revenue guidance reflecting strong organic growth and acquisitions, delivering on this priority.
Delivery assessment Oct 15, 2026
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Incoming Evidence
Compare these dated observations with the operating requirements above
Expectations trend
Same fiscal period
FY2028 · fiscal year ending 2028-09-30 · fmp
FY2028 EPS$55.52
$55.38 → $55.52 · observed estimates
FY2028 revenue$12.56B
$12.43B → $12.56B · observed estimates
Exact estimates & source dates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
FY2028 estimate observations · fmp
Snapshot
EPS
Revenue
EPS / revenue analysts
2026-10-01
$55.38
$12,429,620,232
12 / 18
2026-10-02
$55.38
$12,429,620,232
12 / 17
2026-10-03
$55.38
$12,429,620,232
12 / 17
2026-10-04
$55.38
$12,429,620,232
12 / 17
2026-10-05
$55.38
$12,429,620,232
12 / 17
2026-10-06
$55.52
$12,457,553,956
12 / 17
2026-10-07
$55.52
$12,457,553,956
12 / 17
2026-10-08
$55.46
$12,489,295,532
12 / 17
2026-10-09
$55.33
$12,512,472,003
11 / 17
2026-10-10
$55.33
$12,512,472,003
11 / 17
2026-10-11
$55.33
$12,509,177,885
11 / 17
2026-10-12
$55.45
$12,534,962,356
11 / 17
2026-10-13
$55.45
$12,534,962,356
11 / 17
2026-10-14
$55.52
$12,562,216,474
11 / 17
2026-10-15
$55.52
$12,562,216,474
11 / 17
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
0 raises · 1 cuts · 0 unchanged · 2 without a comparable prior
How this is measured
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Outlook in Brief
The evidence, the remaining questions, and what comes next
What's improving
No recovery evidence is reported in the available driver assessments.
Still unresolved / key risks
Complete acquisition of Stellant Systems for $960 millionDirect metric needs a verified mapping
Share buybacks continue with at least $723 million spent in Q2 2026Direct metric needs a verified mapping
EPS near $34.6 in Q3 2026Diluted EPS: $9.39 per share
Revenue grows to about $10.42 billion in fiscal 2026Revenue: $2.741B
Next proof point
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Risk observations as of Oct 15, 2026 · 277 daily observations. Historical moves are not forecasts.
Read detailed Outlook Company context, assumptions & risks
TransDigm Group outlook in detail
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
What kind of bet this is
This is a multi-year view on a business that is executing a growth strategy through acquisitions and share buybacks. The current thesis state reflects a medium confidence level due to mixed recent performance and sector headwinds.
What's priced into TransDigm Group
The market appears to have priced in a neutral valuation compared to peers, with expectations slightly below average. There is a low fragility tier, indicating that the stock is not overly sensitive to negative news at this time.
What the fundamentals likely do
Management is on track with priorities like increasing revenue guidance and executing share buybacks. However, there is a moderate risk of missing future earnings expectations, as the company has a history of misses.
What TransDigm Group hinges on
The long-term thesis hinges on the performance of sector bellwethers like SPCX, GE, and RTX. If these companies continue to perform well, it could provide a favorable environment for TDG, while any negative shifts could pose risks.
Bottom line
Overall, TDG's fundamentals and management execution suggest a stable outlook, but sector performance will be crucial in the coming years. Not investment advice.
Source: QuarterlyIQ weekly Outlook · Week ending Oct 10, 2026 · Carried forward
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
